MENU
Kiniksa is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines designed to modulate immunological signaling pathways for patients suffering from debilitating diseases with significant unmet medical need.
Kiniksa’s goal is to build a fully-integrated biopharmaceutical company. Our management team and employees are focused on advancing a portfolio of immune-modulating, clinical-stage product candidates that target underserved conditions and offer the potential for differentiation.
Identify and develop a pipeline of product candidates with validated mechanisms of action, strong biologic rationale, and offer the potential for differentiation.
We are relentless and focused on putting patients at the center of everything we do and strive to develop life-changing medicines.
